Monlunabant
A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men
Inversago Pharma · Phase 1 · Completed · Enrollment 73
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Monlunabant dose 1 | n/r | n/r | n/r | n/r | n/r |
| Monlunabant dose 2 | n/r | n/r | n/r | n/r | n/r |
| Monlunabant dose 3 | n/r | n/r | n/r | n/r | n/r |
| Placebo (monlunabant) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.